|
|
|
|
LEADER |
00000cam a2200000Ia 4500 |
001 |
EBSCO_ocn772532901 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
120112s2010 nyua ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d OCLCQ
|d YDXCP
|d E7B
|d OCLCF
|d OCLCQ
|d AGLDB
|d ICA
|d MOR
|d PIFAG
|d OCLCQ
|d U3W
|d D6H
|d STF
|d WRM
|d VTS
|d COCUF
|d NRAMU
|d INT
|d TOF
|d OCLCQ
|d HS0
|d ADU
|d UKCRE
|d AJS
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 961674823
|a 962598917
|a 988511752
|a 992003330
|a 1037939822
|a 1038613933
|a 1045511364
|a 1059111856
|a 1097153540
|a 1112864987
|a 1153456866
|
020 |
|
|
|a 9781617280450
|q (electronic bk.)
|
020 |
|
|
|a 1617280453
|q (electronic bk.)
|
020 |
|
|
|z 9781616689704
|
020 |
|
|
|z 616689706
|
029 |
1 |
|
|a DEBBG
|b BV043961147
|
029 |
1 |
|
|a DEBSZ
|b 481297464
|
029 |
1 |
|
|a NZ1
|b 15345495
|
029 |
1 |
|
|a AU@
|b 000054714094
|
035 |
|
|
|a (OCoLC)772532901
|z (OCoLC)961674823
|z (OCoLC)962598917
|z (OCoLC)988511752
|z (OCoLC)992003330
|z (OCoLC)1037939822
|z (OCoLC)1038613933
|z (OCoLC)1045511364
|z (OCoLC)1059111856
|z (OCoLC)1097153540
|z (OCoLC)1112864987
|z (OCoLC)1153456866
|
037 |
|
|
|n Title subscribed to via ProQuest Academic Complete
|
050 |
|
4 |
|a R850
|b .A38 2010eb
|
072 |
|
7 |
|a MED
|x 108000
|2 bisacsh
|
082 |
0 |
4 |
|a 610.28/4
|2 23
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Advances in medicine and biology.
|n Volume 6 /
|c Leon V. Berhardt, editor.
|
260 |
|
|
|a New York :
|b Nova Biomedical, Nova Biomedical Books,
|c ©2010.
|
300 |
|
|
|a 1 online resource (xii, 282 pages) :
|b illustrations (some color).
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Advances in biology and medicine series
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a ""ADVANCES IN MEDICINE AND BIOLOGY VOLUME 6""; ""CONTENTS""; ""PREFACE""; ""ZINC-BASED BIOMATERIALS""; ""BIOLOGICAL ASPECTS OF ZINC""; ""ZINC BIOMATERIALS""; ""ZINC OXYCHLORIDE CEMENTS""; ""ZINC OXIDE EUGENOL CEMENTS""; ""ZINC PHOSPHATE CEMENTS""; ""ZINC POLYCARBOXYLATE CEMENTS""; ""GLASS POLY(ALKENOATE) CEMENTS""; ""GLASSES USED IN GPCS""; ""ACID COMPONENTS USED IN GPCS""; ""THE ROLE OF ADDITIVES TO GPCS""; ""MECHANICAL PROPERTIES OF GPCS""; ""BIOLOGICAL AND ION RELEASE PROPERTIES OF GPCS""; ""ALUMINIUM FREE GPCS""; ""STRUCTURE AND REACTIVITY OF ALUMINIUM FREE IONOMERGLASSES""
|
505 |
8 |
|
|a ""STRENGTH OF ALUMINIUM-FREE GPCS""""OPTIMISATION OF RHEOLOGICAL PROPERTIES OF ZN-GPCS""; ""IN VITRO ANALYSIS OF ALUMINIUM-FREE GPCS""; ""IN VIVO ANALYSIS OF ALUMINIUM-FREE GPCS""; ""OTHER ASPECTS OF ALUMINIUM-FREE GPCS""; ""APPLICATIONS FOR ALUMINIUM-FREE GPCS""; ""FUTURE PERSPECTIVES OF ALUMINIUM-FREE GPCS""; ""REFERENCES""; ""THE EFFECTS OF DRUGS ON VERBAL FLUENCY:MECHANISMS OF DRUG RELATED FLUENCY INAPHASIA""; ""ABSTRACT""; ""INTRODUCTION""; ""NEUROANATOMY OF SPEECH AND LANGUAGE""; ""NEUROCHEMICAL BASES OF SPEECH AND LANGUAGE""; ""The Primary Neurotransmitters""
|
505 |
8 |
|
|a ""Glutamate, γ-Aminobutyric Acid and Glycine""""Neuromodulators and Hormones""; ""Catecholamines""; ""Acetylcholine""; ""Serotonin""; ""DEFINITION OF FLUENCY""; ""NEUROPHARMACOLOGY OF VERBAL FLUENCY, SPEECH ANDLANGUAGE""; ""Agents which Increase Cerebral Perfusion""; ""Dopaminergic Agents""; ""Amphetamines""; ""Serotonin""; ""Cholinergic Drugs""; ""Piracetam""; ""Zolpidem""; ""Amantadine""; ""Antiepileptic Agents""; ""Drugs which have Speech and Language Side Effects""; ""CLINICAL CASE""; ""CONCLUSION""; ""REFERENCES""; ""PSORIASIS AS A MULTISYSTEMINFLAMMATORY DISEASE""; ""ABSTRACT""
|
505 |
8 |
|
|a ""1. CLINICAL FEATURES OF PSORIASIS""""2. TREATMENT OPTIONS FOR PSORIASIS""; ""3. PATHOGENESIS OF PSORIASIS""; ""4. SYSTEMIC MANIFESTATIONS OF INFLAMMATORYDISORDERS""; ""5. CLINICAL LINK BETWEEN PSORIASIS ANDATHEROSCLEROSIS""; ""6. OPHTHALMIC AND RENAL MANIFESTATIONS OFPSORIASIS""; ""7. SIMILARITIES BETWEEN MOLECULAR MECHANISMS OFPSORIASIS AND OTHER INFLAMMATORY DISORDERS""; ""8. CAN TREATMENT OF PSORIASIS ALSO IMPROVE ITSSYSTEMIC MANIFESTATION?""; ""9. DELINEATING PSORIASIS AS A MULTISYSTEMINFLAMMATORY DISEASE: ""5 YEAR VIEW""""; ""REFERENCES""
|
505 |
8 |
|
|a ""REPACKAGING OF ANTI-GLAUCOMAMEDICINES:NEW THERAPEUTIC VISTAS""""ABSTRACT""; ""INTRODUCTION""; ""CHOLINERGIC AGENTS""; ""Pilocarpine""; ""NON-SELECTIVE ADRENERGIC AGONISTS""; ""CARBONIC ANHYDRASE INHIBITORS""; ""Acetazolamide""; ""Dorzolamide and Brinzolamide""; ""α2-ADRENERGIC AGONIST""; ""BETA-BLOCKING AGENTS""; ""Timolol""; ""Betaxolol""; ""Levobunolol""; ""Carteolol""; ""PROSTAGLANDIN ANALOGS""; ""Unoprostone Isopropylate""; ""Latanoprost""; ""COMBIMATION""; ""CONCLUSION""; ""REFERENCES""; ""THE UTILIZATION OF TECHNOLOGY IN THETREATMENT OF OBSESSIVE COMPULSIVEDISORDER""; ""ABSTRACT""
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Medicine.
|
650 |
|
0 |
|a Biology.
|
650 |
|
2 |
|a Medicine
|
650 |
|
2 |
|a Biology
|
650 |
|
6 |
|a Médecine.
|
650 |
|
6 |
|a Biologie.
|
650 |
|
7 |
|a medicines (material)
|2 aat
|
650 |
|
7 |
|a biology.
|2 aat
|
650 |
|
7 |
|a medicine (discipline)
|2 aat
|
650 |
|
7 |
|a MEDICAL
|x Instruments & Supplies.
|2 bisacsh
|
650 |
|
7 |
|a Biology
|2 fast
|
650 |
|
7 |
|a Medicine
|2 fast
|
700 |
1 |
|
|a Berhardt, Leon V.
|
776 |
0 |
8 |
|i Print version:
|t Advances in medicine and biology. Volume 6.
|d New York : Nova Biomedical, Nova Biomedical Books, ©2010
|z 9781616689704
|
830 |
|
0 |
|a Advances in biology and medicine series.
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=389148
|z Texto completo
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10659023
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 389148
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 7365914
|
994 |
|
|
|a 92
|b IZTAP
|